Cara Therapeutics - CARA - High RIsk Biotech Stocks Buy, Sell, Hold Investing Analysis for the Long-run

Companies / BioTech Sep 28, 2021 - 08:38 PM GMT

Five more biotech stocks to add to the strategy of invest and forget for a potential X10 return. a reminder of why I am engaging in this binge on biotech stocks after having been focused on AI stocks for the past 5 years.

1. Biotech stocks are an unloved stocks sector whilst tech stocks over valued, even the ultra safe stocks such as the Top 10, so I am reluctant to add at current valuations hence why I hit the SELL button for the first time in many years and reduced my exposure to AI stocks by about 40%.

2. That biotech is a derivative of AI, we'll most sectors will soon become a derivative of AI because it is the PRIMARY tech megatrend of our age that will continue to broaden its reach to encompass all sectors of the economy.

3. That one of my former biotech 12xers got taken over (GW Pharma) that flooded my account with cash early May and so that focused my attention on repopulating my portfolio with 10 more biotech stocks where I expect at least 3 to 10x, with most of the rest expected to survive to varying extent. Though this is the stock market and so there are never any guarantees especially where such smallish cap stocks are concerned.

4. Our beloved AI stocks have been BID UP to high valuations, yes including Google, so they are not CHEAP, even after a 10% to 15% correction i.e. the likes of Microsoft and Amazon are discounting a lot of future earnings growth! Of course that does not necessarily mean that they are about to fall to what I would consider to be fair value let lone cheap levels as they did during March 2020 because at the end of the day they are GOOD stocks so usually command a healthy premium to invest in unless there is a market panic that marks everything lower regardless.

I had planned to have completed and posted this analysis shortly after my last biotech stocks analysis (Five More Small Cap Bio and Tech Stocks to Invest for 2021 and Beyond!), but focus shifted to crypto's on how to capitalise on the crypto bear market by investing in a select portfolio of crypto's at various buying levels, that and expectation of a correction would lower the price of these biotech stocks, which has happened even if the general market has held steady.

Analysis Contents

RISK RATINGS
HIGH RISK STOCK BUYING LEVELS
Blueprint Medicines - BPMC - $84.5 - Risk 3
Cara Therapeutics - CARA - $11.94 - Risk 5
Txxxxxxxxxx - Txx - - Risk 1
Bxxxxxxxxxxxxx- Bxxx - Risk 8
Axxxxxxxxxxx - Axxx -- Risk 10
High Risk Stocks Portfolio Buying Levels
Netflix - FAANG a Buy, Sell or Hold?
Trending towards Hyperinflation!
Delta Variant!
Solar CME MULTIPLE Black Swans

DISCLAIMER - Investing in Smallish cap stocks is VERY HIGH RISK. The analysis in this article is a matter of opinion provided for general information purposes only and is not intended as investment advice. Information and analysis derived from sources and utilising methods believed to be reliable, but I cannot accept responsibility for any trading or investing losses that may be incurred as a result of this analysis. Individuals should consult with their personal financial advisors before engaging in any investing or trading activities

Firstly here's a reminder of the small cap bio-tech stocks state of play as per my last analysis of which I now personally hold positions in ALL 4 of the biotech stocks mentioned i.e. ABBV, CRSP, NBX, AVR, all of which are trending in the right direction. Though of course I am focused on many multiples towards 10x many years down the road.

RISK RATINGS

A rating of 1 is the lowest risk and 10 highest risk in terms of something going wrong and the stock effectively crashes and burns into becoming a penny stock or even going bust within the next 5 years! This is based on the sum of all my analysis of each stock and given my risk averse nature then most of the stocks will tend to have a low probability of actually going bust within the next 5 years. Still this rating gives an extra measure of risk vs reward when entertaining potential position sizes.

HIGH RISK STOCK BUYING LEVELS

As is the case with the main AI stocks portfolio I will be listing buying levels which are high probability levels that could be achieved during a correction. What I tend to do is put a price alert at the buying level so if triggered I can decide whether to buy, this means I don't need to waste time monitoring any of my stocks for if they fall I will get an alert, and all I need to do is update the buying levels every so often in response to price action. Of course one can also put in selling level alerts if one is looking to cash out or reduce exposure.

However, for high risk stocks I will be listing 2 buying levels, a near buying level and a more distant buying level. The reason being that I may be more inclined to buy some high risk stocks than others, so if I really want to invest in stock x then I would put the price alert at the near buying level, whilst if I am only interested at much lower prices i.e. as the case with Tesla trades, then I would set the alert to act on the more distant price alert level, of course one can set both price alerts and then make up ones mind at the time they are triggered,

Also I will be include the biotech sector IBB ETF to compare each stocks trend against.

Cara Therapeutics - CARA - $11.94 - Risk 5

Another downtrodden unloved small cap biotech stock with a market cap of $600 million, Cara Therapeutics focused on developing and commercialising chemical entities with a primary focus in pruritus and pain by targeting the opioid receptors. Current PE ratio is 51.2 on earnings of 0.23. Yes the PE is a high, but the PEG ratio is low at 0.5, and as is Price to book at 2.9. As is the case with most of these biotech stocks it's a case of investing and waiting several years for the payoffs to materialise, don't know when the breakthroughs will happen but sometime over the next few years. The company is awash with cash with ZERO debt and has had not debt for the past 5 years which means it has a good chance of having enough time and resources to make it to the breakthroughs.

The stock is trading near its historic low of $9 to $12, so not much down side which compares against the highs of its range of $27 to $30. The share price is very volatile, in fact I would be tempted to range trade it i.e. put a sell limit at $27 to try and capitalize on the volatility with a view to buying back in towards the bottom of the range again.. It does not track the biotech sector much as is the case with most of the small cap stocks they just do their own thing in response to own news events, a X10 target would be about $120, though I would be tempted to let it run to $200. Meanwhile shares were diluted by 7% over the past year. Largest shareholder is Black rock 15%.

The rest of this extensive analysis focused on finding value in unloved biotech stocks with the potential to X10 over the next 5 years has first been made available to Patrons who support my work. So for immediate first access to ALL of my analysis and trend forecasts then do consider becoming a Patron by supporting my work for just $3 per month. https://www.patreon.com/Nadeem_Walayat.

Chasing Value with Five More Biotech Stocks for the Long-run

Contents

RISK RATINGS
HIGH RISK STOCK BUYING LEVELS\
Blueprint Medicines - BPMC - $84.5 - Risk 3
Cara Therapeutics - CARA - $11.94 - Risk 5
Txxxxxxxxxx - Txx - - Risk 1
Bxxxxxxxxxxxxx- Bxxx - Risk 8
Axxxxxxxxxxx - Axxx -- Risk 10
High Risk Stocks Portfolio Buying Levels
Netflix - FAANG a Buy, Sell or Hold?
Trending towards Hyperinflation!
Delta Variant!
Solar CME MULTIPLE Black Swans

And access to my latest extensive analysis on the prospects for the stock market into Mid 2021 see - Stock Market FOMO Hits September Brick Wall - Dow Trend Forecast Sept 2021 to May 2022

Contents:

Stock Market Forecast 2021 Review
Stock Market AI mega-trend Big Picture
US Economy and Stock Market Addicted to Deficit Spending
US Economy Has Been in an Economic Depression Since 2008
Inflation and the Crazy Crypto Markets
Inflation Consequences for the Stock Market
FED Balance Sheet
Weakening Stock Market Breadth
Why Most Stocks May Go Nowhere for the Next 10 Years!
FANG Stocks
Margin Debt
Dow Short-term Trend Analysis
Dow Annual Percent Change
Dow Long-term Trend Analysis
ELLIOTT WAVES Analysis
Stocks and 10 Year Bond Yields
SEASONAL ANALYSIS
Short-term Seasonal Trend
US Presidential Cycle
Best Time of Year to Invest in Stocks
2021 - 2022 Seasonal Investing Pattern
Formulating a Stock Market Trend Forecast
Dow Stock Market Trend Forecast Sept 2021 to May 2022 Conclusion
Investing fundamentals
IBM Continuing to Revolutionise Computing
AI Stocks Portfolio Current State
My Late October Stocks Buying Plan
HIGH RISK STOCKS - Invest and Forget!
Afghanistan The Next Chinese Province, Australia Living on Borrowed Time
CHINA! CHINA! CHINA!
Evergrande China's Lehman's Moment
Aukus Ruckus

So for immediate first access to ALL of my analysis and trend forecasts then do consider becoming a Patron by supporting my work for just $3 per month that is soon set to increase to $4 per month for new Patrons, so a short window of opportunity exists to lock in at $3 per month now before the price hike. https://www.patreon.com/Nadeem_Walayat.

Including access to my recent extensive analysis updating AI stocks buying levels as we head towards the window for a significant correction even a possible stock market crash.

Stock Market FOMO Going into Crash Season, Chinese Stocks and Bitcoin Trend Update

FOMO Fumes on Negative Earnings
Cathy Woods ARK Funds Performance Year to Date - Chinese Stocks Big Mistake
INTEL The Two Steps Forward One Step Back Corporation
AMD Ryzen 3D
New Potential Addition to my AI Stocks Portfolio
Why is Netflix a FAANG Stock?
Stock Market CRASH / Correction
How to Protect Your Self From a Stock Market CRASH / Bear Market?
Chinese Tech Stocks CCP Paranoia
VIES - Variable Interest Entities
CCP Paranoid
Best AI Tech Stocks ETF?
Best UK Investment Trust
AI Stocks Buying Pressure Evaluation
AI Stocks Portfolio Current State
AI Stocks Portfolio KEY
What to Buy Today?
INVEST AND FORGET HIGH RISK STOCKS!
High Risk Stocks KEY
Bitcoin Trend Forecast Current State
Crypto Bear Market Accumulation Current State
Crazy Crypto Exchanges - How to Buy Bitcoin for $42k, Sell for $59k when trading at $47k!

My analysis schedule includes:

Silver Price Trend Analysis, AI Stocks Portfolio Update - 50% Done
How to Get Rich! - 90% done - This is a good 6 month work in progress nearing completion.

UK House Prices Trend Analysis, including an update for the US and a quick look at Canada - 15% done
US Dollar and British Pound analysis
Gold Price Trend Analysis - 10%

Again for immediate access to all my work do consider becoming a Patron by supporting my work for just $3 per month. https://www.patreon.com/Nadeem_Walayat.

And ensure you are subscribed to my ALWAYS FREE newsletter for my next in-depth analysis.

Your calm as a cumcumber 1/3rd full petrol tank analyst.

Nadeem Walayat

http://www.marketoracle.co.uk

Nadeem Walayat has over 35 years experience of trading derivatives, portfolio management and analysing the financial markets, including one of few who both anticipated and Beat the 1987 Crash. Nadeem's forward looking analysis focuses on UK inflation, economy, interest rates and housing market. He is the author of five ebook's in the The Inflation Mega-Trend and Stocks Stealth Bull Market series that can be downloaded for Free.

Nadeem is the Editor of The Market Oracle, a FREE Daily Financial Markets Analysis & Forecasting online publication that presents in-depth analysis from over 1000 experienced analysts on a range of views of the probable direction of the financial markets, thus enabling our readers to arrive at an informed opinion on future market direction. http://www.marketoracle.co.uk

Disclaimer: The above is a matter of opinion provided for general information purposes only and is not intended as investment advice. Information and analysis above are derived from sources and utilising methods believed to be reliable, but we cannot accept responsibility for any trading losses you may incur as a result of this analysis. Individuals should consult with their personal financial advisors before engaging in any trading activities.

Nadeem Walayat Archive

Only logged in users are allowed to post comments. Register/ Log in

The Market Oracle is a FREE Financial Markets Forecasting & Analysis web-site.
(c) 2005-2024 MarketOracle.co.uk (Market Oracle Ltd) - Market Oracle Ltd asserts copyright on all articles authored by our editorial team and all comments posted. Any and all information provided within the web-site, is for general information purposes only and Market Oracle Ltd do not warrant the accuracy, timeliness or suitability of any information provided on this site. nor is or shall be deemed to constitute, financial or any other advice or recommendation by us. and are also not meant to be investment advice or solicitation or recommendation to establish market positions. We do not give investment advice and our comments are an expression of opinion only and should not be construed in any manner whatsoever as recommendations to enter into a market position either stock, option, futures contract, bonds, commodity or any other financial instrument at any time. We recommend that independent professional advice is obtained before you make any investment or trading decisions. By using this site you agree to this sites Terms of Use. From time to time we promote or endorse certain products / services that we believe are worthy of your time and attention. In return for that endorsement and only in the cases where you purchase directly though us may we be compensated by the producers of those products.